HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Refractory epilepsy accompanying acute encephalitis with multifocal cortical lesions: possible autoimmune etiology.

Abstract
We report on a 14-year-old male suffering from acute encephalitis, whose clinical course met the criteria for acute encephalopathy with refractory, repetitive partial seizures (AERRPS). He presented with extremely refractory partial and secondary generalized seizures, and required high-dose barbiturate infusion therapy for 57 days under mechanical ventilation. Seven weeks after onset, the seizures were ameliorated by treatment with sodium bromide, carbamazepine, clobazam, and high-dose phenobarbital. Magnetic resonance imaging on day 14 of admission showed multifocal cortical lesions scattered in the bilateral hemispheres; these disappeared on day 34. Diffuse and mild atrophy of the cerebral cortex, and moderate atrophy of the hippocampus, appeared by day 61. Serum anti-glutamate receptor epsilon2 autoantibodies were detected on day 2. The patient was discharged after 113 days of admission with intractable epilepsy, memory disability, and regression of intelligence. We discuss the etiological significance of the multifocal lesions, which are unusual findings on neuroimaging of AERRPS.
AuthorsTohru Okanishi, Yuka Mori, Tetsuya Kibe, Yukitoshi Takahashi, Yoshiaki Saito, Yoshihiro Maegaki, Kenji Yokochi
JournalBrain & development (Brain Dev) Vol. 29 Issue 9 Pg. 590-4 (Oct 2007) ISSN: 0387-7604 [Print] Netherlands
PMID17442514 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Barbiturates
  • barbituric acid
Topics
  • Adolescent
  • Barbiturates (administration & dosage)
  • Cerebral Cortex (pathology)
  • Drug Administration Schedule
  • Encephalitis (complications, drug therapy, immunology, pathology)
  • Epilepsy (complications, drug therapy, immunology, pathology)
  • Humans
  • Magnetic Resonance Imaging
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: